The pharmaceutical company assumes that its vaccine is also effective against the mutation discovered in Great Britain.
Moderna assumes that its vaccine also protects against the more contagious variant of the Corona virus first detected in Great Britain. This is based on the data available so far, the pharmaceutical company says. Tests are planned for each variant.
On Wednesday, Canada joined the U.S. in allowing the use of the Moderna vaccine, and it is expected to be approved soon in the EU as well.
The Moderna vaccine needs two doses of vaccine four weeks apart to be effective; Pfizer/BioNTech’s preparation, already approved in the EU, has a second dose after three weeks. It requires more extensive refrigeration during transport than Moderna’s vaccine.
In test series, both agents had shown a high efficacy of around 94 percent and few side effects. However, it is still unclear how long the vaccination effect will last, because the treated form of the coronavirus has only been known for about a year.
- hp, source: kurier.at. picture: pixabay.com
This post has already been read 554 times!